General form of registration statement for all companies including face-amount certificate companies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]            
Insured limit $ 250,000   $ 250,000   $ 250,000  
Advertising expense 22,000 $ 0 28,000 $ 3,000 3,000 $ 0
Deferred offering costs         $ 1,800,000 8,000
Property and equipment estimated useful lives         3 years  
Research and development expenses 335,125 248,419 704,741 528,267 $ 1,142,777 1,007,476
Selling, General and Administrative Expenses [Member]            
Product Information [Line Items]            
Patent and annuity costs         $ 236,000 $ 188,000
Selling, General and Administrative Expenses [Member] | Revision of Prior Period, Adjustment [Member]            
Product Information [Line Items]            
Reclassified patent expenses and annuity costs   $ 59,000   $ 101,000    
Diagnostic Test [Member]            
Product Information [Line Items]            
Revenues 7,000   8,000      
Cytometry Services [Member]            
Product Information [Line Items]            
Revenues 3,000   3,000      
U. S. Department Of Defense [Member]            
Product Information [Line Items]            
Revenues $ 10,000   $ 10,000